Although the absolute risk of melanoma at 40 years was small ... The risk was driven in large part by exposure to radiation therapy and specific types of cytotoxic chemotherapy.

The relentless nature of cancer does not mean we are powerless. Medical advancements in precision medicine, immunotherapy, ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant prostate cancer ...

The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, ...

While your risk of developing cancer is typically ... The main cause of melanoma is exposure to ultraviolet light, with UV radiation coming from the sun and tanning beds, and while it is more ...

The study population was at low risk of COVID-19 mortality (obesity 20% ... We selected MRI as the imaging modality (as in UK Biobank) due to (1) safety (no radiation exposure, no need for intravenous ...

Exposure to radiation from head or neck CT imaging increased risk for childhood brain tumors, according to results of a ...

New research suggests moderate sun exposure offers health benefits, challenging traditional protection guidelines and changing public perception.

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...